TrialClinical pharmacology in drug development2025

Pharmacokinetics, Safety, and Tolerability of Single-Dose Dazukibart in Healthy Adults in China and Japan: Results From 2 Randomized, Double-Blind, Phase 1 Studies.

Naihan Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.